Florida adds CVS, Walgreens to opioid lawsuit

Florida expanded the scope of its original opioid lawsuit to include two pharmacy giants, CVS and Walgreens, according to ABC News.

The original lawsuit, filed in May, included four drugmakers: Purdue Pharma, the maker of OxyContin; Endo Pharmaceuticals, the maker of Percocet and Opana; Janssen Pharmaceuticals, the maker of fentanyl drug Duragesic; and Teva Pharmaceutical, a drugmaker that makes generic versions of pain medications.

The expanded complaint alleges the two largest drugstore chains failed to stop suspicious orders of opioids and dispensed unreasonable quantities of opioids from their pharmacies.

According to the complaint, CVS distributed 700 million opioid dosages in Florida between 2006 to 2014. In addition, one Walgreens distribution center supplied 285,800 orders of oxycodone in one month in a town of just 3,000 people.  

"Defendants reaped billions of dollars in revenues while they knew, or should reasonably have known, that they were causing immense harm to the state and its citizens," the lawsuit reads.

Read the full report here.


More articles on pharmacy:
AstraZeneca sells respiratory drug for $1.5B
Express Scripts to launch formulary for lower list price drugs
Nestle pays $98M for increased stake in food allergy drugmaker Aimmune

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Whitepapers

Featured Webinars